A recent study has found that CD44 was able to elevate the expression of programmed death-ligand 1 (PD-L1) by regulating CD274 transcription, resulting in inhibition of the tumor-intrinsic function of PD-L1 (34). This evidence concerns the gene CD44 and neoplasm.